Clinical Trial Update: High Flux Hemodialysis Thrice Versus Once [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing high-flux hemodialysis thrice weekly versus once weekly in end-stage renal disease; status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: National Taiwan University Hospital | Conditions: End-Stage Renal Disease | Phase 3 | Status: UNKNOWN